For research use only. Not for therapeutic Use.
ELOVL6-IN-3(CAT: I040949) is an inhibitor targeting ELOVL6 (elongation of very long-chain fatty acids 6), an enzyme involved in the biosynthesis of long-chain fatty acids. By inhibiting ELOVL6, this compound reduces the production of long-chain fatty acids, which are key components in lipid metabolism. ELOVL6-IN-3 shows potential for use in metabolic disease research, particularly in the regulation of lipid homeostasis and fatty acid synthesis. It may have therapeutic implications for conditions like obesity, insulin resistance, and non-alcoholic fatty liver disease (NAFLD), making it a promising candidate in the treatment of metabolic syndrome and related disorders.
| CAS Number | 712346-06-0 |
| Synonyms | 6,6-dimethyl-3-(5-methyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-5,7-dihydroindole-2,4-dione |
| Molecular Formula | C27H24F3N3O3 |
| Purity | ≥95% |
| IUPAC Name | 6,6-dimethyl-3-(5-methyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-5,7-dihydroindole-2,4-dione |
| InChI | InChI=1S/C27H24F3N3O3/c1-16-21(23(35)33(31-16)18-12-8-5-9-13-18)26(27(28,29)30)22-19(14-25(2,3)15-20(22)34)32(24(26)36)17-10-6-4-7-11-17/h4-13,31H,14-15H2,1-3H3 |
| InChIKey | XNUIQJWHESYIAP-UHFFFAOYSA-N |
| SMILES | CC1=C(C(=O)N(N1)C2=CC=CC=C2)C3(C4=C(CC(CC4=O)(C)C)N(C3=O)C5=CC=CC=C5)C(F)(F)F |
